Menicon Co., Ltd. (TYO:7780)
1,094.00
-8.00 (-0.73%)
May 21, 2025, 3:30 PM JST
Menicon Revenue
In the fiscal year ending March 31, 2025, Menicon had annual revenue of 121.49B JPY with 4.56% growth. Menicon had revenue of 29.98B in the quarter ending March 31, 2025, with 4.14% growth.
Revenue
121.49B
Revenue Growth
+4.56%
P/S Ratio
0.68
Revenue / Employee
28.78M
Employees
4,221
Market Cap
83.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 121.49B | 5.30B | 4.56% |
Mar 31, 2024 | 116.19B | 6.00B | 5.44% |
Mar 31, 2023 | 110.19B | 10.02B | 10.00% |
Mar 31, 2022 | 100.17B | 13.96B | 16.20% |
Mar 31, 2021 | 86.21B | 1.69B | 2.00% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |